Automated breast ultrasound dramatically reduces physician interpretation time

May 3, 2012

Automated breast ultrasound takes an average three minutes of physician time, allowing for quick and more complete breast cancer screening of asymptomatic women with dense breast tissue, a new study shows.

Mammography misses more than one-third of cancers in women with dense breasts, said Rachel Brem, MD, lead author of the study. "Ultrasound can and does detect additional, clinically significant, invasive, node negative breast cancers, that are not seen on mammography, but a hand-held ultrasound screening exam requires 20-30 minutes of physician time. Having a technique that takes just three minutes is a "game-changer" in appropriately screening these women, said Dr. Brem.

The study, conducted at George Washington University Medical School in Washington, DC, quantitatively assessed the time it took for radiologists to interpret automated examinations. The mean reading time for the three radiologists in the study was 173.4 seconds, said Dr. Brem.

Currently automated breast ultrasound is limited in use, although a Food and Drug Administration panel just recently voted in favor of its efficacy and safety. "When automated breast ultrasound is integrated in the screening environment, we will see the detection of smaller, more curable breast cancers. The days of one size fits all approach to are passing. Automated breast ultrasound provides us with a tailored approach based on the individual woman's ," Dr. Brem said. "When the Food and Drug Administration clears automated breast ultrasound for screening, I'm confident we will see a rapid integration of this approach into practice to improve cancer detection in women with dense breasts," she said.

The study will be presented May 3, 2012 at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.

Explore further: Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

Related Stories

Recommended for you

New inhibitor drug shows promise in relapsed leukemia

June 21, 2017

A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers at the Perelman School of Medicine at the University of Pennsylvania ...

Blocking cancer—scientists find new way to combat disease

June 21, 2017

New findings published in Nature Chemical Biology show promise for finding new solutions to treat lung cancer and other deadly diseases. Kentucky continues to lead the nation in incidence and death rates from lung cancer, ...

Could certain hair dyes, relaxers raise breast cancer risk?

June 21, 2017

(HealthDay)—The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.